Novartis N
NOVN
CHF
STOCK MARKET:
SWX
Open
 
...
Price in deferred time of 15 minutes
Last quote
10/22/2024 - 15:08:14
Bid
10/22/2024 - 15:08:19
Bid
Volume
Ask
10/22/2024 - 15:08:19
Ask
Volume
98.72
-1.72 ( -1.71% )
98.71
341
98.72
1,106
More information
Analysis by TheScreener
18.10.2024
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 18.10.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 13.09.2024.
Interest
  Strong
Strong interest since 15.10.2024.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 20.08.2024 at a price of 100.40.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 16.08.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 96.895.
4wk Rel Perf
  0.98%
 
The four week relative performance versus STOXX600 is .
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 15.03.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 1.55%.
Mkt Cap in $bn
  230.78
With a market capitalization >$8bn, NOVARTIS AG is considered a large-cap stock.
G/PE Ratio
  1.02
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  13.62
The estimated PE is for the year 2026.
LT Growth
  10.43%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  19
Over the last seven weeks, an average of 19 analysts provided earnings per share estimates.
Dividend Yield
  3.45%
The twelve month estimated dividend yield represents 46.95% of earnings forecasts.
Beta
  61
For 1% of index variation, the stock varies on average by 0.61%.
Correlation
  0.39
Stock movements are strongly independent of index variations.
Value at Risk
  12.13
The value at risk is estimated at CHF 12.13. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002